Literature DB >> 29206677

Benchmarking Complications Associated with Esophagectomy.

Donald E Low1, Madhan Kumar Kuppusamy1, Derek Alderson2, Ivan Cecconello3, Andrew C Chang4, Gail Darling5, Andrew Davies6, Xavier Benoit D'Journo7, Suzanne S Gisbertz8, S Michael Griffin9, Richard Hardwick10, Arnulf Hoelscher11, Wayne Hofstetter12, Blair Jobe13, Yuko Kitagawa14, Simon Law15, Christophe Mariette16, Nick Maynard17, Christopher R Morse18, Philippe Nafteux19, Manuel Pera20, C S Pramesh21, Sonia Puig22, John V Reynolds23, Wolfgang Schroeder24, Mark Smithers25, B P L Wijnhoven26.   

Abstract

OBJECTIVE: Utilizing a standardized dataset with specific definitions to prospectively collect international data to provide a benchmark for complications and outcomes associated with esophagectomy. SUMMARY OF BACKGROUND DATA: Outcome reporting in oncologic surgery has suffered from the lack of a standardized system for reporting operative results particularly complications. This is particularly the case for esophagectomy affecting the accuracy and relevance of international outcome assessments, clinical trial results, and quality improvement projects.
METHODS: The Esophageal Complications Consensus Group (ECCG) involving 24 high-volume esophageal surgical centers in 14 countries developed a standardized platform for recording complications and quality measures associated with esophagectomy. Using a secure online database (ESODATA.org), ECCG centers prospectively recorded data on all resections according to the ECCG platform from these centers over a 2-year period.
RESULTS: Between January 2015 and December 2016, 2704 resections were entered into the database. All demographic and follow-up data fields were 100% complete. The majority of operations were for cancer (95.6%) and typically located in the distal esophagus (56.2%). Some 1192 patients received neoadjuvant chemoradiation (46.1%) and 763 neoadjuvant chemotherapy (29.5%). Surgical approach involved open procedures in 52.1% and minimally invasive operations in 47.9%. Chest anastomoses were done most commonly (60.7%) and R0 resections were accomplished in 93.4% of patients. The overall incidence of complications was 59% with the most common individual complications being pneumonia (14.6%) and atrial dysrhythmia (14.5%). Anastomotic leak, conduit necrosis, chyle leaks, recurrent nerve injury occurred in 11.4%, 1.3%, 4.7%, and 4.2% of cases, respectively. Clavien-Dindo complications ≥ IIIb occurred in 17.2% of patients. Readmissions occurred in 11.2% of cases and 30- and 90-day mortality was 2.4% and 4.5%, respectively.
CONCLUSION: Standardized methods provide contemporary international benchmarks for reporting outcomes after esophagectomy.

Entities:  

Mesh:

Year:  2019        PMID: 29206677     DOI: 10.1097/SLA.0000000000002611

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  96 in total

1.  Comparison of Outcomes with Semi-mechanical and Circular Stapled Intrathoracic Esophagogastric Anastomosis following Esophagectomy.

Authors:  Fady Yanni; Pritam Singh; Nilanjana Tewari; Simon L Parsons; James A Catton; John Duffy; Neil T Welch; Ravinder S Vohra
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Early oral intake through meticulous chewing after esophagectomy.

Authors:  Ian Wong; Simon Law
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Perioperative Mortality in Cancer Esophagus-a Case Control Study at a High-Volume Regional Cancer Center in South India.

Authors:  Ramachandra Chowdappa; Ajeet Ramamani Tiwari; Ravi Arjunan; Syed Althaf; Rekha V Kumar; Srinivas Chunduri
Journal:  Indian J Surg Oncol       Date:  2018-11-14

4.  Risk factors for anastomotic leakage after surgical resections for esophageal cancer.

Authors:  Jonas Herzberg; Tim Strate; Salman Yousuf Guraya; Human Honarpisheh
Journal:  Langenbecks Arch Surg       Date:  2021-05-15       Impact factor: 3.445

5.  Prevention of intra-thoracic recurrent laryngeal nerve injury with robot-assisted esophagectomy.

Authors:  Kei Hosoda; Masahiro Niihara; Hideki Ushiku; Hiroki Harada; Mikiko Sakuraya; Marie Washio; Keishi Yamashita; Naoki Hiki
Journal:  Langenbecks Arch Surg       Date:  2020-06-03       Impact factor: 3.445

6.  Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience.

Authors:  C A De Pasqual; J Weindelmayer; S Laiti; R La Mendola; M Bencivenga; L Alberti; S Giacopuzzi; G de Manzoni
Journal:  Updates Surg       Date:  2019-08-13

7.  Self-Expanding Metal Stents Versus Endoscopic Vacuum Therapy in Anastomotic Leak Treatment After Oncologic Gastroesophageal Surgery.

Authors:  Felix Berlth; Marc Bludau; Patrick Sven Plum; Till Herbold; Hildegard Christ; Hakan Alakus; Robert Kleinert; Christiane Josephine Bruns; Arnulf Heinrich Hölscher; Seung-Hun Chon
Journal:  J Gastrointest Surg       Date:  2018-10-29       Impact factor: 3.452

8.  Total minimally invasive esophagectomy for esophageal adenocarcinoma reduces postoperative pain and pneumonia compared to hybrid esophagectomy.

Authors:  Felix Berlth; Patrick S Plum; Seung-Hun Chon; Christian A Gutschow; Elfriede Bollschweiler; Arnulf H Hölscher
Journal:  Surg Endosc       Date:  2018-06-21       Impact factor: 4.584

9.  Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study.

Authors:  Alicia S Borggreve; Lucas Goense; Peter S N van Rossum; Sophie E Heethuis; Richard van Hillegersberg; Jan J W Lagendijk; Marnix G E H Lam; Astrid L H M W van Lier; Stella Mook; Jelle P Ruurda; Marco van Vulpen; Francine E M Voncken; Berthe M P Aleman; Annemarieke Bartels-Rutten; Jingfei Ma; Penny Fang; Benjamin C Musall; Steven H Lin; Gert J Meijer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-01-25       Impact factor: 7.038

10.  [Perioperative enhanced recovery after surgery program for Ivor Lewis esophagectomy : First experiences of a high-volume center].

Authors:  C Mallmann; H Drinhaus; H Fuchs; L M Schiffmann; C Cleff; E Schönau; C J Bruns; T Annecke; W Schröder
Journal:  Chirurg       Date:  2021-02       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.